Tumor-infiltrating lymphocytes in triple negative breast cancer

Tumor-infiltrating lymphocytes in triple negative breast cancer

The aim of this retrospective study is to assess the prognostic value of tumor-infiltrating lymphocytes in triple negative breast carcinomas that lack both estrogen, progesterone receptors and Her2 amplification. The group of triple negative carcinomas has worse survival rates than other molecula...

Full description

Bibliographic Details
Main Authors:	L. M. Zakhartseva, M. O. Yanovytska
Format:	Article
Language:	English
Published:	Zaporozhye State Medical University 2020-12-01
Series:	Patologìâ
Subjects:	triple negative breast cancer tumor infiltrating lymphocytes tumor microenvironment prognosis
Online Access:	http://pat.zsmu.edu.ua/article/view/221722/223137

Similar Items

TUMOR-INFILTRATING LYMPHOCYTES IN TRIPLE NEGATIVE BREAST CANCER: CORRELATIVE ANALYSES OF OWN DATA AND LITERATURE REVIEW
by: Liubov Zakhartseva, et al.
Published: (2019-06-01)

THE ROLE OF TUMOR-INFILTRATING LYMPHOCYTES IN TRIPLE NEGATIVE BREAST CANCER
by: Anca Zgura, et al.
Published: (2018-09-01)

Prognostic Factors and Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer
by: Özgecan Dülgar, et al.
Published: (2020-10-01)

LAG-3+ tumor-infiltrating lymphocytes ameliorates overall survival in triple-negative breast cancer patients
by: Guoming Hu, et al.
Published: (2023-01-01)

Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
by: Jesse Lopes da Silva, et al.
Published: (2021-11-01)

A Computational Tumor-Infiltrating Lymphocyte Assessment Method Comparable with Visual Reporting Guidelines for Triple-Negative Breast Cancer
by: Peng Sun, et al.
Published: (2021-08-01)

Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis
by: Guoxuan Gao, et al.
Published: (2020-03-01)

Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast
by: Hajime Kuroda, et al.
Published: (2021-03-01)

Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer
by: Carlos Alexander Huertas-Caro, et al.
Published: (2022-07-01)

Tumor‐infiltrating lymphocyte transfusion in a patient with treatment refractory triple negative breast cancer
by: Arielle Jacover, et al.
Published: (2023-12-01)

Immunity and cancer: role of tumor-infiltrating lymphocytes in triple-negative breast cancer
by: Ana Tečić-Vuger, et al.
Published: (2021-01-01)

Correlation Between Mammographic Radiomics Features and the Level of Tumor-Infiltrating Lymphocytes in Patients With Triple-Negative Breast Cancer
by: Hongwei Yu, et al.
Published: (2020-04-01)

Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer
by: Guan-Hua Su, et al.
Published: (2022-10-01)

Syndecan-1 as an immunogene in Triple-negative breast cancer: regulation tumor-infiltrating lymphocyte in the tumor microenviroment and EMT by TGFb1/Smad pathway
by: Ying Zhong, et al.
Published: (2023-04-01)

Clinical and radiomics integrated nomogram for preoperative prediction of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer
by: Ling Hu, et al.
Published: (2024-03-01)

Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers
by: Miao Ruan, et al.
Published: (2018-08-01)

The role of tumor-infiltrating lymphocytes in triple-negative breast cancer and the research progress of adoptive cell therapy
by: Ruonan Li, et al.
Published: (2023-05-01)

Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy
by: Sotiris Loizides, et al.
Published: (2023-01-01)

Identification of the pyroptosis-related prognostic gene signature and characterization of tumor microenvironment infiltration in triple-negative breast cancer
by: Ji Liu, et al.
Published: (2022-08-01)

Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast Cancer
by: Sung Gwe Ahn, et al.
Published: (2015-09-01)

3D Collagen Fiber Concentration Regulates Treg Cell Infiltration in Triple Negative Breast Cancer
by: Huan Gao, et al.
Published: (2022-06-01)

Advances in Tumour-Infiltrating Lymphocytes for Triple-Negative Breast Cancer Management
by: Gorenšek R, et al.
Published: (2023-11-01)

Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer
by: Nour Abuhadra, et al.
Published: (2022-03-01)

Optimized tumour infiltrating lymphocyte assessment for triple negative breast cancer prognostics
by: Maschenka CA. Balkenhol, et al.
Published: (2021-04-01)

Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy
by: Sylvie Giacchetti, et al.
Published: (2022-03-01)

Comprehensive analysis of glycolysis mediated pattern clusters and immune infiltration characterization of tumor microenvironment in triple-negative breast cancer
by: Ji Liu, et al.
Published: (2023-04-01)

Evaluation of triple negative breast cancer with heterogeneous immune infiltration
by: Ángela Quintana, et al.
Published: (2023-05-01)

Metformin Inducing the Change of Functional and Exhausted Phenotypic Tumor-Infiltrated Lymphocytes and the Correlation with JNK Signal Pathway in Triple-Negative Breast Cancer
by: Wang R, et al.
Published: (2022-12-01)

Prognostic Significance of Lymphocyte Infiltrate Localization in Triple-Negative Breast Cancer
by: Toni Čeprnja, et al.
Published: (2022-06-01)

Tumor Microenvironment: Key Players in Triple Negative Breast Cancer Immunomodulation
by: Hongmei Zheng, et al.
Published: (2021-07-01)

Progress on Tumor Infiltrating Lymphocytes in Immunotherapy and Prognosis Evaluation of Breast Cancer
by: HONG Chenchen, et al.
Published: (2022-11-01)

Prognostic Role and Clinical Significance of Tumor-Infiltrating Lymphocyte (TIL) and Programmed Death Ligand 1 (PD-L1) Expression in Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis Study
by: Parisa Lotfinejad, et al.
Published: (2020-09-01)

Association between p53 Expression and Amount of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
by: Miseon Lee, et al.
Published: (2019-05-01)

Relation Between CD8+T Lymphocyte Infiltration and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer
by: KONG Tiandong, et al.
Published: (2021-05-01)

Pilose antler polypeptides promote chemosensitization and T-cell infiltration of triple-negative breast cancer
by: Mohan Li, et al.
Published: (2021-10-01)

The Association of Tumor-Infiltrating Lymphocytes and Programmed Cell Death 1 Expression with the Incidence of Distant Metastasis in Triple-Negative Breast Cancer Subjects in Sanglah General Hospital, Bali, Indonesia
by: I Wayan Sudarsa, et al.
Published: (2021-03-01)

Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective Trial
by: Nour Abuhadra, et al.
Published: (2023-06-01)

High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs
by: Hiroko Onagi, et al.
Published: (2022-10-01)

Association of androgen receptor and tumour-infiltrating lymphocytes with bone recurrence in triple-negative breast cancer
by: Petra Ilenič, et al.
Published: (2024-02-01)

Ki67 Index Changes and Tumor-Infiltrating Lymphocyte Levels Impact the Prognosis of Triple-Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy
by: Yihua Wang, et al.
Published: (2021-06-01)